Search Results
Nico Gagelmann | EBMT 2019 | Outcomes of patients with high-risk cytogenetics undergoing SCT in MM
Case Review: MM with High-Risk Cytogenetics
Gareth Morgan | ESH MM 2019 | The impact of "double-hit" genetics on patient outcomes in MM
Jonathan Keats | ESH MM 2019 | Defining high-risk disease & treatment strategies in multiple myeloma
Managing post-transplant complications in myeloma
Meta-analysis: anti-BCMA CAR-T in R/R myeloma
Hermann Einsele | EBMT 2019 | CAR T therapy versus targeted antibodies in multiple myeloma
Case 2: Double Refractory Patient with High-risk Cytogenetics
Undergoing An Autologous Stem Cell Transplant Now Or Later Makes No Difference in Multiple Myeloma
Risk Assessment of Multiple Myeloma
Nico Gagelmann, MD, Discusses the Young EHA Session on Early Career Advancement
Expanding accessibility to CAR-T therapy
